News

Geron Corp. quits stem cell work

 

The Menlo Park-based biotechnology firm Geron Corp. announced recently that it was abandoning its stem cell research in favor of focusing on two cancer drugs.

The motivation appears financial, according to a statement issued by the company.

"The decision to narrow Geron's technology and therapeutic focus was made after a strategic review of the costs, value inflection timelines and clinical, manufacturing and regulatory complexities," the company said.

As a result, 66 jobs -- 38 percent of its workforce -- will be eliminated, the company said.

The news came as a blow to those hoping to benefit from stem cell therapy, a field that held promise for those paralyzed by spinal cord injuries.

Stem cells possess the ability to become any other type of cell in the body, leading Geron's scientists to explore how to grow the cells into replacement neurons that could reverse paralysis.

We can't do it without you.
Support local journalism.

Comments

Sorry, but further commenting on this topic has been closed.

Be the first to know

Get the latest headlines sent straight to your inbox every day.

First Sunnyvale, then Australia: Mountain View's Le Plonc plots expansion
By Elena Kadvany | 1 comment | 2,349 views

Juggling Renewables
By Sherry Listgarten | 24 comments | 1,757 views

Premarital and Couples: Living as Roommates?
By Chandrama Anderson | 2 comments | 1,327 views

Homestead Faire at Hidden Villa 4/27
By Laura Stec | 0 comments | 501 views

A trial run
By Cheryl Bac | 0 comments | 500 views

 

The Almanac Readers' Choice ballot is here

It's time to decide what local business is worthy of the title "The Almanac Readers' Choice" — and you get to decide! Cast your ballot online. Voting ends May 27th. Stay tuned for the results in the July 17th issue of The Almanac.

VOTE HERE